Inspirion Wealth Advisors’s ADMA Biologics ADMA Stock Holding History

Inspirion Wealth Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.1K	Sell	10,000 -300	-3%	-$2.73K	0.01%	185
2026 Q1	$92.8K	Hold	10,300	–	–	0.01%	175
2025 Q4	$188K	Sell	10,300 -1,300	-11%	-$21.9K	0.02%	165
2025 Q3	$232K	Buy	11,600 +1,300	+13%	+$22.3K	0.03%	136
2025 Q2	$188K	Sell	10,300 -900	-8%	-$18.4K	0.02%	152
2025 Q1	$222K	Hold	11,200	–	–	0.03%	139
2024 Q4	$205K	Sell	11,200 -400	-3%	-$7.53K	0.03%	142
2024 Q3	$232K	Sell	11,600 -400	-3%	-$6.22K	0.03%	137
2024 Q2	$134K	Hold	12,000	–	–	0.02%	144
2024 Q1	$79.2K	Hold	12,000	–	–	0.01%	147
2023 Q4	$54.6K	Buy	+12,000	New	+$44.4K	0.01%	136

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Inspirion Wealth Advisors's ADMA Position: Q2 2026 in Review

Inspirion Wealth Advisors reduced its ADMA Biologics (ADMA) stake by 2.9% in Q2 2026, selling an estimated $2.73K and leaving 10,000 shares worth $86.1K. The position accounts for 0.01% of the portfolio, ranked #185.

Inspirion Wealth Advisors first reported a position in ADMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $232K in Q3 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Inspirion Wealth Advisors held 10,000 shares of ADMA Biologics worth $86.1K as of Q2 2026.
Inspirion Wealth Advisors sold 300 ADMA Biologics shares in Q2 2026, an estimated $2.73K.
ADMA Biologics made up 0.01% of Inspirion Wealth Advisors's portfolio in Q2 2026, its #185 holding.
Inspirion Wealth Advisors first reported a position in ADMA Biologics in Q4 2023 and has held it in 11 quarters since.
Inspirion Wealth Advisors's ADMA Biologics position peaked at $232K in Q3 2025.
323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.